FCGR3A and COVID-19: Conversely, other studies previously demonstrated that CD16 was downregulated in COVID-19 patients during the acute phase, as well as in convalescent subjects [51], suggesting a proinflammatory phenotype of NK cells during SARS-CoV-2 infection.